Product Reports Resources Pricing Login Book a demo
COMPANY PROFILE

GRIN Therapeutics

Request full access

Developing potent therapies for neurological and psychiatric disorders with a focus on negative allosteric modulators

New York City, United StatesFounded 2021Biotech & Life Sciences

About GRIN Therapeutics

GRIN Therapeutics, Inc. is a biotechnology company focused on developing advanced therapies for neurological and psychiatric disorders. Operating in the pharmaceutical and healthcare sectors, the company targets conditions such as FCD Type II, a rare neurodevelopmental disorder. GRIN Therapeutics leverages its expertise in negative allosteric modulators to create potent investigational drugs like radiprodil, which has received Priority Medicine PRIME designation from the European Medicines Agency. The company's business model revolves around research and development, aiming to bring effective treatments to market through clinical trials and regulatory approvals. Revenue is generated through the commercialization of successful therapies and potential partnerships with other pharmaceutical entities. GRIN Therapeutics serves a global market, addressing unmet medical needs and providing solutions for patients with complex neurological conditions.

Source: Dealroom company data

At a glance

Status
Operational
Open positions
None listed
Dealroom signal
25.0/100
Industry
Health
Sub-industry
BioTechnology
Sector
Biotechnology, Drug Development, Neurology, Biotech and Pharma, AI Drug Discovery, DT and LS
Business model
Manufacturing
Client focus
B2B

Funding history

1 recorded event

Company financing events and reported valuations.

Deal typeDateAmountValuationInvestorsSource
SERIES DOther financing May 2025 $140M $560M Blackstone · Angelini Pharma ↗
Showing the latest 1 of 1 recorded eventsBook a demo for the full funding history →

Growth signals

GRIN Therapeutics website traffic

Latest recorded traffic for GRIN Therapeutics is 2.1K monthly website visits, up 0% over the last three months.

Latest monthly visits2.1K 3-month web change0%
Summary metrics are public; monthly history is available with a demoCompare with peers →

Similar companies

Closest operating peers by Dealroom taxonomy

Company identity and context are open; selected comparison metrics preview what is available on the platform.

Showing 8 of the closest matchesCompare every metric →

Investments and acquisitions

Capital deployed

Recent portfolio relationships for companies that also act as investors or acquirers.

GRIN Therapeutics in the New York City ecosystem

Live from Dealroom

The GRIN Therapeutics office with the hot startups, most funded companies and investors around it. Hover or tap a pin.

Loading the map…

Dealroom maps whole ecosystems like this one for cities, regions and governments. See the ecosystem platform →

Investors

2 investors on the cap table

From Dealroom's funding and investor records, grouped by the round each investor first entered.

Series B and later2 investors entered at this stage

Team profiled 1 named & role-tagged
Founders Hidden — book a demo/100 quality score
Key operators Hidden — book a demo quality score
Potential founders Hidden — book a demo likely future founders
Startup mafia Hidden — book a demo alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Global footprint

Workforce and web traffic by country
Workforce by country
2 countries with
team presence
🇺🇸 United States60%
🇬🇧 United Kingdom40%
2 countries shown

Market sentiment

Posts on X, past 7 days

An AI-synthesised read of the highest-engagement posts about GRIN Therapeutics on X, ranked by likes and reposts, corporate channels excluded.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See GRIN Therapeutics’s full profile on Dealroom

Request a free trial to see the complete deal history, financials, people graph and growth signals.

Takes under a minute. Already use Dealroom? Log in.